GILEAD SCIENCES, INC. Effective Tax Rate
GILEAD SCIENCES, INC. (GILD) reported Effective Tax Rate of -2.40% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-06
- GILEAD SCIENCES, INC. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was -2.40%, a 112.44% decline year-over-year.
- GILEAD SCIENCES, INC. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 21.70%, a 7.43% increase year-over-year.
- GILEAD SCIENCES, INC. effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was 16.20%.
- GILEAD SCIENCES, INC. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 19.30%, a 9.81% decline year-over-year.
- GILEAD SCIENCES, INC. effective income tax rate reconciliation, percent for fiscal 2025 was 13.10%, a 57.05% decline from fiscal 2024.
- GILEAD SCIENCES, INC. effective income tax rate reconciliation, percent for fiscal 2024 was 30.50%, a 67.58% increase from fiscal 2023.
- GILEAD SCIENCES, INC. effective income tax rate reconciliation, percent for fiscal 2023 was 18.20%, a 15.35% decline from fiscal 2022.
- GILEAD SCIENCES, INC. effective income tax rate reconciliation, percent for fiscal 2022 was 21.50%, a 14.34% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -2.40% 10-Q · filed 2026-08-06 | -10.40% 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 21.70% 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | 13.10% 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | 16.20% 10-Q · filed 2025-11-07 | 18.00% 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 19.30% 10-Q · filed 2026-08-06 | 19.70% 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 20.20% 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | 30.50% 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -31.10% 10-Q · filed 2025-11-07 | 11.80% 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | 21.40% 10-Q · filed 2025-08-07 | -5.10% 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | 7.00% 10-Q · filed 2025-05-07 | ||||
| 2023-12-31 | 18.20% 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | 6.30% 10-Q · filed 2024-11-12 | 19.40% 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 34.60% 10-Q · filed 2024-08-08 | 29.90% 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | 24.30% 10-Q · filed 2024-05-08 | ||||
| 2022-12-31 | 21.50% 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | 26.60% 10-Q · filed 2023-11-07 | 22.50% 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | 24.50% 10-Q · filed 2023-08-04 | 15.10% 10-Q · filed 2023-08-04 | |||
| 2022-03-31 | 107.90% 10-Q · filed 2023-05-03 | ||||
| 2021-12-31 | 25.10% 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | 24.80% 10-Q · filed 2022-11-02 | 22.50% 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | 16.50% 10-Q · filed 2022-08-08 | 20.60% 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | 23.90% 10-Q · filed 2022-05-04 | ||||
| 2020-12-31 | 94.70% 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | 57.20% 10-Q · filed 2021-11-03 | -903.40% 10-Q · filed 2021-11-03 | |||
| 2020-06-30 | -12.50% 10-Q · filed 2021-08-05 | -86.40% 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | 23.20% 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | -4.00% 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | 22.20% 10-Q · filed 2020-11-04 | 17.90% 10-Q · filed 2020-11-04 | |||
| 2019-06-30 | 22.20% 10-Q · filed 2020-08-06 | 19.30% 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | 16.30% 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | 30.00% 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | 21.20% 10-Q · filed 2019-11-05 | 19.50% 10-Q · filed 2019-11-05 | |||
| 2018-06-30 | 12.80% 10-Q · filed 2019-08-06 | 18.50% 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | 24.30% 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | 65.70% 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | 26.10% 10-Q · filed 2017-11-07 | 25.60% 10-Q · filed 2017-11-07 | |||
| 2017-06-30 | 25.40% 10-Q · filed 2017-08-07 | 25.40% 10-Q · filed 2017-08-07 | |||
| 2017-03-31 | 25.40% 10-Q · filed 2017-05-10 | ||||
| 2016-12-31 | 21.10% 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | 22.20% 10-Q · filed 2016-11-07 | 21.20% 10-Q · filed 2016-11-07 | |||
| 2016-06-30 | 20.50% 10-Q · filed 2016-08-05 | 20.60% 10-Q · filed 2016-08-05 | |||
| 2016-03-31 | 20.80% 10-Q · filed 2016-05-06 | ||||
| 2015-12-31 | 16.40% 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | 16.10% 10-Q · filed 2015-11-04 | 17.30% 10-Q · filed 2015-11-04 | |||
| 2015-06-30 | 18.40% 10-Q · filed 2015-08-05 | 17.90% 10-Q · filed 2015-08-05 | |||
| 2015-03-31 | 17.30% 10-Q · filed 2015-05-08 | ||||
| 2014-12-31 | 18.80% 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | 19.20% 10-Q · filed 2014-11-05 | 19.10% 10-Q · filed 2014-11-05 | |||
| 2014-06-30 | 15.20% 10-Q · filed 2014-08-04 | 19.10% 10-Q · filed 2014-08-04 | |||
| 2014-03-31 | 24.60% 10-Q · filed 2014-05-07 | ||||
| 2013-12-31 | 27.30% 10-K · filed 2016-02-24 | ||||
| 2013-09-30 | 27.30% 10-Q · filed 2013-10-31 | 26.60% 10-Q · filed 2013-10-31 | |||
| 2013-06-30 | 28.60% 10-Q · filed 2013-08-01 | 26.30% 10-Q · filed 2013-08-01 | |||
| 2013-03-31 | 23.70% 10-Q · filed 2013-05-08 | ||||
| 2012-12-31 | 28.70% 10-K · filed 2015-02-25 | ||||
| 2012-09-30 | 29.40% 10-Q · filed 2012-11-06 | 29.90% 10-Q · filed 2012-11-06 | |||
| 2012-06-30 | 27.20% 10-Q · filed 2012-08-01 | 30.20% 10-Q · filed 2012-08-01 | |||
| 2012-03-31 | 34.60% 10-Q · filed 2012-05-04 | ||||
| 2011-09-30 | 24.40% 10-Q · filed 2011-11-04 | 24.90% 10-Q · filed 2011-11-04 | |||
| 2011-03-31 | 24.40% 10-Q · filed 2011-08-05 | 26.00% 10-Q · filed 2011-05-09 | |||
| 2010-09-30 | 26.90% 10-Q · filed 2010-11-08 | 27.30% 10-Q · filed 2010-11-08 | |||
| 2010-06-30 | 28.60% 10-Q · filed 2010-08-09 | 27.50% 10-Q · filed 2010-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |